CLINICAL_TRIALS
trial_result
· 2018-06-15
Clinical Trial Update: KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL) [Phase 2]
Summary
Phase 2 trial update on KW-0761 (mogamulizumab) in adults with previously treated Adult T-cell Leukemia-Lymphoma; results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kyowa Kirin, Inc. | Conditions: Adult T-cell Leukemia-Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2018-06-15